{"id":1589,"date":"2015-01-18T21:11:46","date_gmt":"2015-01-18T21:11:46","guid":{"rendered":"https:\/\/palladiumcapital.com\/?page_id=1589"},"modified":"2015-01-19T00:25:30","modified_gmt":"2015-01-19T00:25:30","slug":"av-therapeutics-inc","status":"publish","type":"page","link":"https:\/\/www.palladiumcapital.com\/client-profiles\/av-therapeutics-inc\/","title":{"rendered":"AV Therapeutics Inc."},"content":{"rendered":"<table>\n<tbody>\n<tr>\n<td colspan=\"4\">\n<table class=\"client-links aligncenter\" align=\"center\">\n<tbody>\n<tr>\n<td><a href=\"http:\/\/www.avth.net\/\" target=\"_blank\"><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-full wp-image-1577\" src=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2015\/01\/icon-home.gif\" alt=\"icon-home\" width=\"35\" height=\"34\" \/><\/a><\/td>\n<td><a href=\"http:\/\/finance.yahoo.com\/echarts?s=AVTH+Interactive#\" target=\"_blank\"><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-full wp-image-1576\" src=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2015\/01\/icon-chart.gif\" alt=\"icon-chart\" width=\"30\" height=\"34\" \/><\/a><\/td>\n<td><a href=\"http:\/\/finance.yahoo.com\/q?s=AVTH&amp;ql=0\" target=\"_blank\"><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-full wp-image-1578\" src=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2015\/01\/icon-info.gif\" alt=\"icon-info\" width=\"30\" height=\"34\" \/><\/a><\/td>\n<td><a href=\"http:\/\/www.google.com\/search?hl=en&amp;gl=us&amp;tbm=nws&amp;authuser=0&amp;q=%22AV+Therapeutics+Inc.%22++&amp;oq=%22AV+Therapeutics+Inc.%22++&amp;gs_l=news-cc.3..43j43i53.3789.15820.0.16743.7.3.0.4.0.0.179.341.2j1.3.0...0.0...1ac.1.6QLg9YbSdKU&amp;gws_rd=ssl\" target=\"_blank\"><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-full wp-image-1579\" src=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2015\/01\/icon-news.gif\" alt=\"icon-news\" width=\"39\" height=\"33\" \/><\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"4\">\n<table class=\"tombstones aligncenter\">\n<tbody>\n<tr>\n<td colspan=\"2\"><a href=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2013\/07\/AVTH-Tombstone-550-000.jpg\"><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-medium wp-image-1398\" src=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2013\/07\/AVTH-Tombstone-550-000-263x300.jpg\" alt=\"AVTH Tombstone 550 000\" width=\"263\" height=\"300\" srcset=\"https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2013\/07\/AVTH-Tombstone-550-000-263x300.jpg 263w, https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2013\/07\/AVTH-Tombstone-550-000.jpg 570w\" sizes=\"(max-width: 263px) 100vw, 263px\" \/><\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>AVT is primarily engaged in the business of developing Cancer therapeutics and immunotherapeutic vaccines that can be used together with prevalent treatment modalities such as chemotherapy and radiation to treat active disease and to prevent metastases and recurrence. Scientists at AVT have identified and patented a chemotherapeutic drug called Capridine that has shown in preclinical models to have specific activity against prostate and colon cancer. This drug is expected to be the frontline AVT product specifically in prostate cancer where no chemotherapy exists at present. The Company\u2019s immunotherapeutics is based on the ability of certain proprietary reagents to re-educate or reprogram a failed immune system that can target previously unidentified micro-metastases. The Company intends to clinically develop both of these approaches independently specifically for prostate cancer.<br \/>\nThe Company is conducting its research by providing funding to an academic institution(s) to conduct its research as this type of funding arrangement makes the most economic sense for start-up research. Therefore, in the future, the Company intends to expand its research efforts by identifying other promising research and funding that research through the researcher\u2019s respective academic institution(s). The market for the Company\u2019s products is very large. Just the drug alone and one successful vaccine against one type of cancer could result in a market potential worth billions. The proprietary technology is easily adaptable to infectious diseases enhancing the market potential several folds. The Company does not intend to market its own products. The Company intends to enter into agreements with large pharmaceutical companies whereby AVT will enjoy an upfront cash sum plus an ongoing royalty stream when the drug\/vaccine(s) are approved by the FDA (Federal Drug Agency) for use in the market.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AVT is primarily engaged in the business of developing Cancer therapeutics and immunotherapeutic vaccines that can be used together with prevalent treatment modalities such as chemotherapy and radiation to treat active disease and to prevent metastases and recurrence. Scientists at AVT have identified and patented a chemotherapeutic drug called Capridine that has shown in preclinical [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1557,"parent":22,"menu_order":0,"comment_status":"open","ping_status":"closed","template":"page-templates\/client-profile.php","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/pages\/1589"}],"collection":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/comments?post=1589"}],"version-history":[{"count":0,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/pages\/1589\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/pages\/22"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/media\/1557"}],"wp:attachment":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/media?parent=1589"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}